Table 1.
Participant characteristics
Participant ID | Sex | Age (years) | Severity | Level | Post-injury (years) | Cause of SCI | Daily spasticity medications |
---|---|---|---|---|---|---|---|
1 | M | 40 | C | T2 | 2 | Fall | None |
2 | M | 37 | A | C6 | 14 | MVA | 40 mg Baclofen |
3 | M | 32 | B | T5 | 7 | MVA | 80 mg Baclofen Marijuana (2–3 mg/day) |
4 | F | 24 | C | C5 | 5 | MVA | None |
5 | M | 39 | A | T5 | 3 | MVA | None |
6 | M | 49 | C | T10 | 3 | Bleed | 60 mg Baclofen |
7 | M | 39 | C | T2 | 1 | MVA | 80 mg Baclofen 5 mg Tizanidine |